Cargando…

FDG-PET/CT–based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy

The impact of [(18)F]fluorodeoxyglucose-positron emission tomography (PET)/computed tomography (CT) restaging on management decisions and outcomes in patients with locally advanced pancreatic carcinoma (LAPC) scheduled for concurrent chemoradiotherapy (CRT) is examined. Seventy-one consecutive patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Topkan, Erkan, Parlak, Cem, Yapar, Ali Fuat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	e-Med 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830425/ https://www.ncbi.nlm.nih.gov/pubmed/24240137 http://dx.doi.org/10.1102/1470-7330.2013.0035

Ejemplares similares

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2011)

Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy
por: Parlak, Cem, et al.
Publicado: (2012)

Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinoma
por: Topkan, Erkan, et al.
Publicado: (2008)

Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
por: Topkan, Erkan, et al.
Publicado: (2012)

The Use of (18)F-FDG PET/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma
por: Hlongwa, Khanyisile N., et al.
Publicado: (2022)

Usefulness of 18f-FDG PET-CT in Staging, Restaging, and Response Assessment in Pediatric Rhabdomyosarcoma
por: Donner, Davide, et al.
Publicado: (2020)

18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
por: Castello, Angelo, et al.
Publicado: (2020)

Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma
por: Pehlivan, Berrin, et al.
Publicado: (2009)

Incidental Detection of Pseudomembranous Colitis Through (18)F-FDG PET/CT During the Restaging of Colorectal Cancer
por: Filippi, Luca
Publicado: (2023)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

Bilateral glomus tumor treated with PET-CT based conformal radiotherapy: a case report
por: Onal, Cem, et al.
Publicado: (2009)

Metformin-Induced Intense Bowel Uptake Observed on Restaging FDG PET/CT Study in a Patient with Gastric Lymphoma
por: Yılmaz, Sabire, et al.
Publicado: (2011)

A Comparison between (18)F-FDG PET/CT Imaging and Biological and Radiological Findings in Restaging of Hepatoblastoma Patients
por: Cistaro, Angelina, et al.
Publicado: (2013)

Significance of (18)F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting
por: Rasheed, Rashid, et al.
Publicado: (2020)

Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids
por: Prasad, Vikas, et al.
Publicado: (2015)

Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy
por: Onal, Cem, et al.
Publicado: (2021)

Comparison of Diagnostic Efficacy of [(68)Ga]Ga-FAPI-04 and [(18)F]FDG PET/CT for Staging and Restaging of Gastric Cancer
por: Zhang, Shumao, et al.
Publicado: (2022)

PET/CT planning during chemoradiotherapy for esophageal cancer
por: Seol, Ki Ho, et al.
Publicado: (2014)

(18)F-FDG PET/CT Imaging in an Unusual Case of Cutaneous Melanoma Arising From Congenital Melanocytic Nevus in a Two-year-old Girl
por: Erhamamcı, Seval, et al.
Publicado: (2021)

The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Liu, Guo-Chen, et al.
Publicado: (2015)

(18)F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
por: Anderegg, Maarten C. J., et al.
Publicado: (2015)

Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer
por: Barakat, Andrew, et al.
Publicado: (2020)

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
por: von Eyben, Rie, et al.
Publicado: (2023)

Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses
por: Onal, Cem, et al.
Publicado: (2009)

Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy
por: Ozdemir, Yurday, et al.
Publicado: (2020)

Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
por: Yilmaz, Busra, et al.
Publicado: (2021)

COVID-19 in an asymptomatic patient undergoing FDG PET/CT
por: Johnson, Lisa N., et al.
Publicado: (2020)

Metabolic patterns on [(18)F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
por: Holzgreve, Adrien, et al.
Publicado: (2023)

Combined Intravenous Urogram and 68Ga-PSMA PET/ CT for Improved Staging and Restaging of Prostate Cancer
por: McBean, Rhiannon, et al.
Publicado: (2020)

Utility of Restaging MRI Following Neoadjuvant Chemoradiotherapy for Stage II-III Rectal Adenocarcinoma
por: Aryan, Mahmoud, et al.
Publicado: (2021)

(18)F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?
por: Li, Yan, et al.
Publicado: (2020)

High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy
por: Haksoyler, Veysel, et al.
Publicado: (2021)

Planned FDG PET-CT Scan in Follow-Up Detects Disease Progression in Patients With Locally Advanced NSCLC Receiving Curative Chemoradiotherapy Earlier Than Standard CT
por: Pan, Yi, et al.
Publicado: (2015)

Forced diuresis and dual-phase (18)F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers
por: Harkirat, S, et al.
Publicado: (2010)

FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements
por: Osman, Medhat M., et al.
Publicado: (2011)

Colonic Malignant Melanoma: (18)F-FDG PET/CT Findings
por: Kaya, Eser, et al.
Publicado: (2018)

Diagnostic and Clinical Impact of 18F-FDG PET/CT in Staging and Restaging Soft-Tissue Sarcomas of the Extremities and Trunk: Mono-Institutional Retrospective Study of a Sarcoma Referral Center
por: Annovazzi, Alessio, et al.
Publicado: (2020)

Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study
por: Spijkers, Suzanne, et al.
Publicado: (2021)

Baker’s Cyst on F-18 FDG PET/CT in a Patient with Ocular Melanoma
por: Cayvarlı, Hakan, et al.
Publicado: (2012)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3hdm7m5rjqsbcn8gp45vnmgt93